Issue |
E3S Web Conf.
Volume 147, 2020
The 3rd International Symposium on Marine and Fisheries Research (3rd ISMFR)
|
|
---|---|---|
Article Number | 01001 | |
Number of page(s) | 11 | |
Section | Aquaculture | |
DOI | https://doi.org/10.1051/e3sconf/202014701001 | |
Published online | 10 February 2020 |
Review Vibriosis Management in Indonesian Marine Fish Farming
1
Laboratory of Fish Health and Environment, Fisheries Department, Faculty of Agriculture, Gadjah Mada University, Yogyakarta, Indonesia 55281
2
Laboratory of Aquaculture, Fisheries Department, Faculty of Agriculture, Gadjah Mada University, Yogyakarta, Indonesia 55281
* Corresponding author: indah_ist@ugm.ac.id
Vibriosis is a bacterial disease that has been reported in Indonesian marine fish culture since the 1990s. The disease was reported mostly in grouper and shrimp (monodon and vanname) farming, although the infections in snapper (Lates calcarifer) and abalone (Haliotis squamata) aquaculture were also occurred. Causative agents of vibriosis in Indonesia marine fish is involving 14 species of vibrio namely Vibrio harveyi, V. anguillarum, V. alginoluticus, V. parahaemolyticus, V. fluvialis, V. furnisii, V. methcnikovii, V. vulnificus, V. ordalii, V. cincinnatiensis, V. carchariae, V. azureus, V. mimicus and V. damsela. Control of vibriosis is conducted with water quality management, applications of vaccines, antibiotics, probiotics and immunostimulants. Most vaccines developed and commercially available in Indonesia are in the form of inactive-whole cell types. The vaccine product is effective enough to protect fish from vibriosis. Probiotics have been widely studied since the 2000s and have been shown to increase fish and shrimp growth and resistances against vibriosis. Immunostimulants began to be developed since 2010 based on the extracts of terrestrial plants, seaweeds and chitosan. It is therefore concluded that the continuous existence of pathogenic strains in aquaculture farm requires further development of the control methods, including periodic updating of the vaccines, probiotics and immunostimulant formulas for more potent efficacies.
© The Authors, published by EDP Sciences, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.